SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ — Medit has launched a mobile app, MEDIT M, available to users starting December 18, 2024.
This much-anticipated release addresses key features requested by dental professionals and aims to improve collaboration and efficiency between clinics and labs.
Key Features
Revolutionizing Dental Workflows with MEDIT M
MEDIT M simplifies digital dentistry by enabling real-time collaboration and seamless workflows for dental professionals. With its user-friendly interface, the app is designed to meet the specific needs of the industry.
It enhances workflow efficiency and convenience by providing instant notifications and chat features for fast, effective communication. Fully integrated with Medit Link, the app offers mobile access to patient and case data.
Users can quickly view 3D scan data, which helps reduce errors and improve outcomes. Additionally, the app streamlines workflows, saving time by eliminating unnecessary steps and boosting overall productivity.
Availability and Support
MEDIT M will be available for download from the Google Play Store and App Store. To assist users, comprehensive guides and onboarding materials are available through the official Medit website.
About Medit
Medit is a leading provider of digital dentistry solutions, committed to advancing the field with innovative technologies and customer support. Through continuous innovation, Medit helps dental professionals achieve exceptional results while driving the industry forward.
SOURCE Medit
NEW YORK CITY, NY / ACCESS Newswire / January 10, 2026 / The phrase best…
CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…
Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…
Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…
Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…
Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…